KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Acquisitions: 2017-2023

Historic Acquisitions for Exact Sciences (EXAS) over the last 7 years, with Dec 2023 value amounting to $52.4 million.

  • Exact Sciences' Acquisitions fell 84.30% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $66.4 million, marking a year-over-year decrease of 32.82%. This contributed to the annual value of $52.4 million for FY2023, which is 256.89% up from last year.
  • Exact Sciences' Acquisitions amounted to $52.4 million in FY2023, which was up 256.89% from $14.7 million recorded in FY2022.
  • Exact Sciences' Acquisitions' 5-year high stood at $973.9 million during FY2019, with a 5-year trough of $6.7 million in FY2020.
  • In the last 3 years, Exact Sciences' Acquisitions had a median value of $52.4 million in 2023 and averaged $188.9 million.
  • Its Acquisitions has fluctuated over the past 5 years, first tumbled by 99.32% in 2020, then skyrocketed by 7,405.71% in 2021.
  • Exact Sciences' Acquisitions (Yearly) stood at $973.9 million in 2019, then slumped by 99.32% to $6.7 million in 2020, then soared by 7,405.71% to $499.7 million in 2021, then slumped by 97.06% to $14.7 million in 2022, then surged by 256.89% to $52.4 million in 2023.